Genetic proof-of-concept for cardiac gene expression in human circulating blood-derived progenitor cells.

To the Editor: Transplantation of adult bone marrow– or blood-derived autologous progenitor cells is a promising option for treatment of patients with acute myocardial infarction or heart failure. Initial randomized, double-blind clinical trials demonstrated encouraging results suggesting that